US 11,944,693 B2
Method for delivering an active agent
Robert Wayne Glenn, Jr., Liberty Township, OH (US); Gregory Charles Gordon, Loveland, OH (US); Mark Robert Sivik, Mason, OH (US); Mark Ryan Richards, Wayne Township, OH (US); Stephen Wayne Heinzman, Cincinnati, OH (US); Michael David James, Cincinnati, OH (US); Geoffrey William Reynolds, Montgomery, OH (US); Paul Dennis Trokhan, Hamilton, OH (US); Alyssandrea Hope Hamad-Ebrahimpour, Cincinnati, OH (US); Frank William Denome, Cincinnati, OH (US); and Stephen Joseph Hodson, Frankling, OH (US)
Assigned to The Procter & Gamble Company, Cincinnati, OH (US)
Filed by The Procter & Gamble Company, Cincinnati, OH (US)
Filed on Jul. 16, 2018, as Appl. No. 16/035,760.
Application 16/035,760 is a continuation of application No. 14/730,658, filed on Jun. 4, 2015, granted, now 10,045,915.
Application 14/730,658 is a continuation of application No. 13/229,838, filed on Sep. 12, 2011, granted, now 9,074,305, issued on Jul. 7, 2015.
Application 13/229,838 is a continuation of application No. PCT/US2011/042667, filed on Jun. 30, 2011.
Claims priority of provisional application 61/361,159, filed on Jul. 2, 2010.
Prior Publication US 2018/0338890 A1, Nov. 29, 2018
Int. Cl. C11D 17/04 (2006.01); A61K 8/02 (2006.01); A61K 9/70 (2006.01); A61L 27/50 (2006.01); A61L 27/54 (2006.01); A61Q 5/00 (2006.01); B08B 9/20 (2006.01); D01F 1/10 (2006.01); D06L 1/00 (2017.01)
CPC A61K 8/0204 (2013.01) [A61L 27/50 (2013.01); A61L 27/54 (2013.01); A61Q 5/00 (2013.01); B08B 9/20 (2013.01); C11D 17/042 (2013.01); C11D 17/047 (2013.01); D01F 1/10 (2013.01); D06L 1/00 (2013.01); A61L 2300/602 (2013.01)] 19 Claims
 
1. A method for delivering one or more oral care active agents to a mammal's mouth, the method comprising the steps:
a. providing a water-soluble nonwoven web comprising a plurality of water-soluble meltblown filaments and/or fibers produced from a filament-forming composition comprising from about 20% to about 80% by weight of the filament-forming composition of water, wherein the plurality of water-soluble meltblown filaments and/or fibers comprise of only one water-soluble filament-forming material and two or more oral care active agents present in the water-soluble filament-forming material that are releasable from the plurality of water-soluble meltblown filaments and/or fibers when the plurality of water-soluble meltblown filaments and/or fibers are exposed to conditions of intended use, wherein the total level of the water-soluble filament-forming material present in the plurality of water-soluble meltblown filaments and/or fibers is 80% or less by weight on a dry filament basis and the total level of the two or more oral care active agents present in the plurality of water-soluble meltblown filaments and/or fibers is 20% or greater by weight on a dry filament basis; and
b. triggering the release of at least one of the two or more oral care active agents from the plurality of water-soluble meltblown filaments and/or fibers.